BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $131 at Cantor Fitzgerald
Tweet Send to a Friend
Cantor Fitzgerald analyst Alethia Young raised the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $131.00 (from $126.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
